| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Heart and Circulatory Physiology, Vol 272, Issue 3 1220-H1230, Copyright © 1997 by American Physiological Society
ARTICLES |
J. S. Ikonomidis, T. Shirai, R. D. Weisel, B. Derylo, V. Rao, C. I. Whiteside, D. A. Mickle and R. K. Li
Department of Clinical Biochemistry, University of Toronto, Ontario, Canada.
We showed previously that 20 min of low-volume anoxia ("ischemia") and 20 min of "reperfusion" preconditions quiescent pediatric myocyte cultures against damage resulting from 90 min of subsequent prolonged ischemia and 30 min of reperfusion. The purpose of this study was to assess the roles of adenosine and protein kinase C (PKC) in this preconditioning model. Our results suggest that 1) preconditioned myocytes secrete a protective mediator(s) into the "ischemic" supernatant that is transferable to other cells, and adenosine is released into the supernatant in quantities sufficient for adenosine-receptor activation (2) preconditioning is inhibited by adenosine-receptor antagonism, and myocyte protection similar to preconditioning can be achieved with exogenously administered adenosine or adenosine-receptor stimulation; (3) brief ischemic and adenosine-induced myocyte preconditioning is mimicked by the phorbol ester 4beta-phorbol 12-myristate 13-acetate (PKC agonist) and inhibited by PKC antagonists; and (4) brief ischemic and adenosine-induced myocyte preconditioning both induce PKC translocation to myocyte membranes and increase the PKC phosphorylation rate. These data suggest that adenosine released from ischemic human pediatric myocytes mediates preconditioning through activation of PKC.
This article has been cited by other articles:
|
|
 |
|
  T.-B. Liu, P. W. M. Fedak, R. D. Weisel, T. Yasuda, G. Kiani, D. A. G. Mickle, Z.-Q. Jia, and R.-K. Li Enhanced IGF-1 expression improves smooth muscle cell engraftment after cell transplantation Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2840 - H2849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. YELLON and J. M. DOWNEY Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology Physiol Rev, October 1, 2003; 83(4): 1113 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Shiono, V. Rao, R. D. Weisel, M. Kawasaki, R.-K. Li, D. A. G. Mickle, P. W. M. Fedak, L. C. Tumiati, L. Ko, and S. Verma L-Arginine protects human heart cells from low-volume anoxia and reoxygenation Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H805 - H815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Yellon and A. Dana The Preconditioning Phenomenon : A Tool for the Scientist or a Clinical Reality? Circ. Res., September 29, 2000; 87(7): 543 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Hopper, C. R. Forrest, H. Xu, A. Zhong, W. He, J. Rutka, P. Neligan, and C. Y. Pang Role and mechanism of PKC in ischemic preconditioning of pig skeletal muscle against infarction Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2000; 279(2): R666 - R676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Marber Ischemic Preconditioning in Isolated Cells Circ. Res., May 12, 2000; 86(9): 926 - 931. [Full Text] [PDF]
|
|
|
|
 |
|
 T. N. James Homage to James B. Herrick: A Contemporary Look at Myocardial Infarction and at Sickle-Cell Heart Disease : The 32nd Annual Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association Circulation, April 18, 2000; 101(15): 1874 - 1887. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Tian, W. Miao, M. Spindler, M. M. Javadpour, R. McKinney, J. C. Bowman, P. M. Buttrick, and J. S. Ingwall Long-term expression of protein kinase C in adult mouse hearts improves postischemic recovery PNAS, November 9, 1999; 96(23): 13536 - 13541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Rao, F. Merante, R. D. Weisel, T. Shirai, J. S. Ikonomidis, G. Cohen, L. C. Tumiati, N. Shiono, R.-K. Li, D. A. Mickle, et al. Insulin stimulates pyruvate dehydrogenase and protects humanventricular cardiomyocytes from simulated ischemia J. Thorac. Cardiovasc. Surg., September 1, 1998; 116(3): 485 - 489. [Abstract] [Full Text]
|
|
|
|
|
|
C. Weinbrenner, C. P. Baines, G.-S. Liu, S. C. Armstrong, C. E. Ganote, A. H. Walsh, R. E. Honkanen, M. V. Cohen, and J. M. Downey Fostriecin, an Inhibitor of Protein Phosphatase 2A, Limits Myocardial Infarct Size Even When Administered After Onset of Ischemia Circulation, September 1, 1998; 98(9): 899 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shirai, V. Rao, R. D. Weisel, J. S. Ikonomidis, R.-K. Li, L. C. Tumiati, F. Merante, and D. A. Mickle Preconditioning human cardiomyocytes and endothelial cells J. Thorac. Cardiovasc. Surg., January 1, 1998; 115(1): 210 - 214. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
